“Impact of GLP-1 Receptor Agonists on Cardiovascular Risk Reduction in Patients With Type 2 Diabetes”. Journal of Carcinogenesis, vol. 24, no. 10s, Nov. 2025, pp. 141-53, https://doi.org/10.64149/.